PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA. schapoval@som.umaryland.edu.\', \'Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, 800 West Baltimore Street, Baltimore, MD, 21201, USA. schapoval@som.umaryland.edu.\', \'Program in Oncology at the Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA. schapoval@som.umaryland.edu.\', \'SemaPlex LLC, Ellicott City, MD, USA. schapoval@som.umaryland.edu.\', \'Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.\', \'Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, 800 West Baltimore Street, Baltimore, MD, 21201, USA.\', \'Program in Oncology at the Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.\', \'VA Maryland Health Care System, Baltimore VA Medical Center, Baltimore, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s10020-021-00423-y
?:hasPublicationType
?:journal
  • Molecular medicine (Cambridge, Mass.)
is ?:pmid of
?:pmid
?:pmid
  • 34961486
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all